Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers discover new antibiotic in African ant
petri dish
The new species is a member of the Streptomycin bacteria family.
Tests show antibiotic is highly-effective against MRSA

Researchers have discovered a new species of antibiotic, produced by the bacteria of an African ant, that is highly effective against MRSA.

The finding, published in the journal Chemical Science, was made by scientists at the University of East Anglia and the John Innes Centre.

The new species is a member of the Streptomycin bacteria family and was discovered on the African fungus-growing plant-ant, Tertraponera penzigi.

Tests show that the antibiotic is potent against antibiotic-resistant 'superbugs' such as methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE).

Professor Wilkinson from the John Innes Centre commented: “Our finding highlights the importance of searching as-yet under-expired environments, which, when combined with recent advances in genome sequencing and editing, enables the discovery of new species making natural product antibiotics which could prove invaluable in the fight against AMR.”

Currently, nearly all of the antibiotics in use originate from a group of bacteria called actinomycetes. This bacteria was isolated from soil between 40 and 80 years ago, in what is known as the ‘golden age’ of antibiotic discovery.

Since then, inappropriate use of these antibiotics has led to widespread antimicrobial resistance where disease-causing bacteria have become resistant to some of these antibiotics.

“We have been exploring the chemical ecology of protective symbioses formed between antibiotic-producing bacteria and fungus-growing insects to better understand how these associations are formed and explore them as a new source of anti-infective drugs,” said Prof Matt Hutchings from the University of East Anglia.

“Kenyan plant-ants live in symbiosis with thorny acacia trees. They live and breed in domatia - which are hollowed out structures which the plant evolved to house them - and grow fungus in them for food. In return, they protect the plants from large herbivores including elephants, which won't eat plants covered in ants.”

The antibiotic has been named ‘streptomyces formicae,’ and the antibiotics formicamycins, after the latin formica, meaning ant.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.